Home
Mail
TV
News
Sport
Finance
Lifestyle
Entertainment
Weather
Mobile
Yahoo
Mail
Cost Of Living
Watchlists
My Portfolios
Markets
Money
Work
Technology
Industries
Give Feedback
Australia markets closed
ALL ORDS
7,837.40
-100.10
(-1.26%)
ASX 200
7,575.90
-107.10
(-1.39%)
AUD/USD
0.6535
+0.0012
(+0.18%)
OIL
83.66
+0.09
(+0.11%)
GOLD
2,349.60
+7.10
(+0.30%)
Bitcoin AUD
96,776.29
-1,085.23
(-1.11%)
Bellerophon Therapeutics, Inc. (BLPH)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0554
+0.0004
(+0.73%)
At close: 02:10PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
Operating expenses
Research development
15,808
16,362
13,015
17,890
Selling general and administrative
5,764
6,022
7,146
8,386
Total operating expenses
21,572
22,384
20,161
26,276
Operating income or loss
-21,572
-22,384
-20,161
-26,276
Interest expense
-
-
-
250
Total other income/expenses net
-
1
600
-327
Income before tax
-21,504
-22,248
-19,556
-26,853
Income tax expense
-2,417
-2,417
-1,800
-2,125
Income from continuing operations
-19,087
-19,831
-17,756
-24,728
Net income
-19,087
-19,831
-17,756
-24,728
Net income available to common shareholders
-19,087
-19,831
-17,756
-24,728
Basic EPS
-0.89
-2.08
-1.87
-3.17
Diluted EPS
-0.89
-2.08
-1.87
-3.17
Basic average shares
11,103
9,551
9,503
7,797
Diluted average shares
11,103
9,551
9,503
7,797
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.